Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Antimicrobial Proteins

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic modification of the marine-derived yeast Yarrowia lipolytica with high-protein content using a GPI-anchor-fusion expression system.

Biotechnology progress·2009

Same author

Regulation of the Edwardsiella tarda hemolysin gene and luxS by EthR.

Journal of microbiology and biotechnology·2009

Same author

EBV LMP2A-specific T cell immune responses elicited by dendritic cells loaded with LMP2A protein.

Cellular & molecular immunology·2009

Same author

[Combination of volar buttress plate with external fixator for the distal radial fractures of type C3 caused by high-energy injuries].

Zhongguo gu shang = China journal of orthopaedics and traumatology·2009

Same author

Environmental regulation of floral anthocyanin synthesis in Ipomoea purpurea.

Molecular ecology·2009

Same author

PI3K integrates the effects of insulin and leptin on large-conductance Ca2+-activated K+ channels in neuropeptide Y neurons of the hypothalamic arcuate nucleus.

American journal of physiology. Endocrinology and metabolism·2009

Search research articles

Related Experiment Video

Updated: May 27, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Antitumor peptides from marine organisms.

Lan-Hong Zheng¹, Yue-Jun Wang¹, Jun Sheng¹

¹Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao 266071, China.

|November 11, 2011

Summary

Marine organisms offer a vast source of novel antitumor peptides. This review details their biological properties, molecular diversity, and mechanisms, highlighting potential cancer therapies.

Keywords:

antitumor marine organisms peptides

More Related Videos

Identification of Hemolytic and Phospholipase Activity in Crude Extracts from Sea Anemones by Straightforward Bioassays

Identification of Hemolytic and Phospholipase Activity in Crude Extracts from Sea Anemones by Straightforward Bioassays

Published on: March 29, 2022

Related Experiment Videos

Last Updated: May 27, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Identification of Hemolytic and Phospholipase Activity in Crude Extracts from Sea Anemones by Straightforward Bioassays

Identification of Hemolytic and Phospholipase Activity in Crude Extracts from Sea Anemones by Straightforward Bioassays

Published on: March 29, 2022

Area of Science:

Marine Biology
Pharmacology
Biochemistry

Background:

Marine biodiversity represents a rich source of novel bioactive compounds.
Marine-derived bioactive substances are increasingly explored for therapeutic applications, particularly in oncology.
Peptides isolated from marine organisms show significant potential as anticancer agents.

Purpose of the Study:

To review the progress in the study of antitumor peptides derived from marine sources.
To describe the biological properties and mechanisms of action of various marine peptides.
To present the molecular diversity and pharmacological properties of novel marine antitumor peptides.

Main Methods:

Literature review of studies on marine-derived antitumor peptides.
Analysis of biological activities, including induction of apoptosis, effects on tubulin-microtubule dynamics, and angiogenesis inhibition.
Compilation of data on molecular diversity and pharmacological characteristics.

Main Results:

Marine peptides exhibit diverse mechanisms against cancer, including apoptosis induction, disruption of microtubule formation, and anti-angiogenic effects.
Significant molecular diversity exists among marine antitumor peptides, offering a wide range of structural and functional possibilities.
Several novel marine peptides demonstrate promising pharmacological properties for cancer treatment.

Conclusions:

Marine-derived peptides are a valuable resource for the discovery of new anticancer drugs.
Further research into marine bioactive substances can lead to the development of effective antitumor agents.
Understanding the mechanisms of action and molecular diversity of these peptides is crucial for advancing marine-based cancer therapy.